Exagen Appoints Ana Hooker to Board of Directors
July 30, 2021 08:25 ET
|
Exagen Inc.
SAN DIEGO, July 30, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, is proud to announce the addition of Ms. Ana Hooker as an additional...
Scipher Medicine Increases Patient Access for Prismra® by Expanding Intended Use in Autoimmune Patients
July 29, 2021 09:22 ET
|
Scipher Medicine Corporation
Expanded intended use for the blood test validated in Network-004 study.Now, most rheumatoid arthritis patients can be tested at any point in their clinical journey.Test enables providers to identify...
Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference
July 29, 2021 08:25 ET
|
Exagen Inc.
SAN DIEGO, July 29, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the Canaccord Genuity 41st Annual...
AVISE® Lupus Test Demonstrates Statistically Significant Clinical Utility in Achieving a Definitive SLE Diagnosis and Positively Impacts Treatment Decisions
July 13, 2021 16:05 ET
|
Exagen Inc.
SAN DIEGO, July 13, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, announced today the publication of their latest clinical utility study in...
Exagen Elects Frank Stokes to Board of Directors
June 18, 2021 08:29 ET
|
Exagen Inc.
SAN DIEGO, June 18, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, is proud to announce the company’s stockholders approved the election of...
Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature
June 10, 2021 02:00 ET
|
Nucleome Therapeutics
Nucleome Therapeutics announces publication of a novel method enabling 3D genome mapping at single base pair resolution in the journal Nature New method is being used by Nucleome to unlock the...
Scipher Medicine and Leading Medical Researchers in Network and Data Science Compress Time to Identify COVID-19 Treatments From Years to Months
June 08, 2021 08:00 ET
|
Scipher Medicine Corporation
Study demonstrates Scipher Medicine’s ability to analyze patient data to identify novel treatments.Scipher will focus on pharma collaborations in autoimmune diseases. WALTHAM, Mass., June 08, 2021 ...
Aeterna Zentaris Engages Dr. Michael Levy to Support Development of Autoimmune and Inflammatory CNS Disorders Programs
June 07, 2021 08:05 ET
|
Aeterna Zentaris Inc
– Dr. Levy is a well-established neuroimmunologist with extensive experience and expertise in the area of neuroimmunology, autoimmune and CNS disorders – Company continues to advance development of...
Nucleome Therapeutics announces appointment of Dr Jonathan Hepple as a Non-Executive Director to its Board
May 25, 2021 02:00 ET
|
Nucleome Therapeutics
Nucleome Therapeutics announces appointment of Dr Jonathan Hepple as a Non-Executive Director to its Board Nucleome’s unique technology platform has the potential to discover precision therapeutics...
Exagen Inc. to Participate in the William Blair 41st Annual Growth Stock Conference
May 24, 2021 16:05 ET
|
Exagen Inc.
SAN DIEGO, May 24, 2021 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the William Blair 41st Annual Growth...